ISAL 2019 | Progress in ALL & trends in the survival of young adult patients in Sweden and the USA

Name: Progress in ALL & trends in the survival of young adult patients in Sweden and the USA
Uploaded: 2019-03-15T11:31:16.000Z
Duration: 5 min 3 s
Description: Magnus Björkholm, MD, PhD, of the Karolinska Institute, Stockholm, Sweden, speaks at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany. He discusses the trends in survival of young adult patients with acute lymphoblastic leukemia (ALL) in Sweden and the USA, including the aims behind this work and possible reasons for the results seen.

Magnus Björkholm • 15 Mar 2019

ISAL 2019

Acute Lymphoblastic Leukemia Leukemia

Magnus Björkholm, MD, PhD, of the Karolinska Institute, Stockholm, Sweden, speaks at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany. He discusses the trends in survival of young adult patients with acute lymphoblastic leukemia (ALL) in Sweden and the USA, including the aims behind this work and possible reasons for the results seen.